alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# Court of Appeals

**First District of Texas**

BILL OF COSTS

No. 01

- 11

- 00333

- CV

Andrew Whallon, Dahlia Garcia and Richard Grayshaw

v

.

City of Houston

NO. 0851588 IN THE 270TH DISTRICT COURT OF HARRIS C OUNTY

TYPE OF FEE CHARGES PAID/DUE STATUS PAID BY

MT FEE

SUPP CLK RECORD

MT FEE

MT FEE

MT FEE

MT FEE

MT FEE

MT FEE

MT FEE

RPT RECORD

CLK RECORD

CLK RECORD

MT FEE

SUPP CLK RECORD

MT FEE

MT FEE

MT FEE

E

- TXGOV FEE

E

- TXGOV FEE

E

- TXGOV FEE

E

- TXGOV FEE

MT FEE

E

- TXGOV FEE $10.00

$18.00

$10.00

$15.00

$10.00

$10.00

$10.00

$15.00

$10.00

$3,183.90

$119.00

$37.00

$10.00

$524.00

$10.00

$10.00

$10.00

$5.00

$5.00

$5.00

$5.00

$10.00

$5.00 03/10/2015

11/13/2014

09/29/2014

09/29/201 4

09/29/2014

09/29/2014

09/25/2014

08/15/2014

07/29/2014

05/20/2014

05/15/2014

03/19/2014

03/04/2014

03/03/2014

01/09/2014

12/02/2013

11/04/2013

11/04/2013

10/31/2013

10/31/2013

09/17/2013

09/17/2013

08/15/2013 E

- PAID

PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAI D

PAID

PAID

PAID

E

- PAID

PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID ANT

ANT

ANT

ANT

ANT

AN T

ANT

ANT

ANT

ANT

ANT

ANT

ANT

ANT

APE

APE

APE

ANT

ANT

ANT

APE

APE

ANTMT FEE

E

- TXGOV FEE

E

- TXGOV FEE

E

- TXGOV FEE

E

- TXGOV FEE

MT FEE

E

- TXGOV FEE

E

- TXGOV FEE

MT FEE

E

- TXGOV FEE

E

- TXGOV FEE

MT FEE

E

- TXGOV FEE

MT FEE

E

- TXGOV FEE

MT FEE

CLK RECORD

MT FEE

FILING $10.00

$5.00

$5.00

$5.00

$5.00

$10.00

$5.00

$5.00

$15.00

$5.00

$5.00

$15.00

$5.00

$10.00

$4.00

$10.00

$197.00

$10.00

$175.00 08/15/2013

0 8/15/2013

08/15/2013

08/15/2013

08/14/2013

08/09/2013

08/09/2013

06/03/2013

04/12/2013

04/12/2013

02/15/2013

02/15/2013

02/04/2013

02/04/2013

08/02/2012

08/02/2012

12/13/2011

06/10/2011

05/13/2011 E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

E

- PAID

PAID

PAID

PAID ANT

ANT

ANT

ANT

ANT

ANT

ANT

APE

ANT

ANT

ANT

ANT

ANT

ANT

ANT

ANT

ANT

APE

ANT



### The costs incurred on appeal to the First Court of Appeals Houston, Texas are

$4,5 47 .90.

Court costs in this case have been taxed in this Court’s judgment

I, Christopher A. Prine

, Clerk o f the Court of Appeals for the First District of Texas, do hereby

certify that this is a true statement of the costs of appeal in this case.

IN TESTIMONY WHEREOF, witness my

hand and the seal of the Court of Appeals for the

First District of Texas, this April 17 , 2015

.
# C_2022159EN.01002101.xml

| 12.4.2022 | EN | Official Journal of the European Union | C 159/21 |
| --- | --- | --- | --- |

12.4.2022

EN

Official Journal of the European Union

C 159/21

---

Prior notification of a concentration

(Case M.10716 – PLD / NBIM / TARGET ASSET BLEISWIJK)

Candidate case for simplified procedure

(Text with EEA relevance)

(2022/C 159/12)

1.

This notification concerns the following undertakings:

| — | Prologis, L.P. (‘PLD’, United States of America), |
| --- | --- |

—

Prologis, L.P. (‘PLD’, United States of America),

| — | Norges Bank Investment Management (‘NBIM’, Norway), |
| --- | --- |

—

Norges Bank Investment Management (‘NBIM’, Norway),

| — | Target Asset (Netherlands). |
| --- | --- |

—

Target Asset (Netherlands).

PLD and NBIM will acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of the Target Asset.

The concentration is accomplished by way of purchase of shares.

2.

| — | PLD owns, operates and develops real estate properties, mainly for industrial purposes, in the Americas, Europe and Asia, |
| --- | --- |

—

PLD owns, operates and develops real estate properties, mainly for industrial purposes, in the Americas, Europe and Asia,

| — | NBIM provides institutional investment for the Government Pension Fund Global on behalf of the Norwegian Ministry of Finance, focusing on worldwide investments including real estate investments in North America, Europe and Japan, |
| --- | --- |

—

NBIM provides institutional investment for the Government Pension Fund Global on behalf of the Norwegian Ministry of Finance, focusing on worldwide investments including real estate investments in North America, Europe and Japan,

| — | The Target Asset is a real estate property located in Bleiswijk, the Netherlands, which is used as a logistics facility. |
| --- | --- |

—

The Target Asset is a real estate property located in Bleiswijk, the Netherlands, which is used as a logistics facility.

3.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.10716 – PLD / NBIM / TARGET ASSET BLEISWIJK

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

| European Commission |
| --- |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

1

(2)  OJ C 366, 14.12.2013, p. 5.

2

---
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2819 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 2819

   To amend the Public Health Service Act to make certain provisions 
relating to health insurance inapplicable in a State that does not have 
an exchange established by the State under section 1311 of the Patient 
                  Protection and Affordable Care Act.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 18, 2015

 Mr. Gosar (for himself, Mrs. Blackburn, Mr. DesJarlais, Mr. Fleming, 
 Mr. Franks of Arizona, Mr. Jody B. Hice of Georgia, and Mr. Miller of 
   Florida) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
   To amend the Public Health Service Act to make certain provisions 
relating to health insurance inapplicable in a State that does not have 
an exchange established by the State under section 1311 of the Patient 
                  Protection and Affordable Care Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Premium Reduction and Insurance 
Market Reform Act of 2015''.

SEC. 2. INAPPLICABILITY OF CERTAIN HEALTH INSURANCE PROVISIONS IN 
              CERTAIN STATES.

    Section 2724 of the Public Health Service Act (42 U.S.C. 300gg-23) 
is amended--
            (1) in subsection (a)(1), by striking ``subsection (b)'' 
        and inserting ``subsections (b) and (e)''; and
            (2) by adding after subsection (d) the following new 
        subsection--
    ``(e) Exception for Plans in Certain States.--In the case of a 
group health plan, and a health insurance issuer offering group or 
individual health insurance coverage, in a State that does not have an 
exchange established by the State under section 1311 of the Patient 
Protection and Affordable Care Act, the following provisions of this 
title shall not apply:
            ``(1) The limitation on age rating premiums for adults in 
        section 2701(a)(1)(A)(iii).
            ``(2) Section 2707.
            ``(3) Section 2713.''.
                                 <all>
```
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 298 Introduced in House (IH)]

114th CONGRESS
  1st Session
                                H. R. 298

   To amend chapter V of the Federal Food, Drug, and Cosmetic Act to 
   permit the sale of, and access to, ``research use only'' products.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 13, 2015

Mr. Burgess (for himself and Ms. Speier) introduced the following bill; 
       which was referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
   To amend chapter V of the Federal Food, Drug, and Cosmetic Act to 
   permit the sale of, and access to, ``research use only'' products.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medical Testing Availability Act of 
2015''.

SEC. 2. CLARIFICATION REGARDING RESEARCH USE ONLY PRODUCTS.

    Section 520 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
360j) is amended by adding at the end the following subsection:
    ``(o) Products With Research Use Only Labeling.--
            ``(1) In general.--A product whose labeling bears the 
        statement described in section 809.10(c)(2)(i) of title 21, 
        Code of Federal Regulations, as in effect on the date of the 
        enactment of this subsection, may not be deemed to be 
        adulterated or misbranded under this Act on the basis that the 
        manufacturer or distributor of the product--
                    ``(A) sells the product to an end user who uses the 
                product in a manner inconsistent with such statement; 
                or
                    ``(B) engages in business communications regarding 
                the product with an end user of the product.
            ``(2) Business communications defined.--In this subsection, 
        the term `business communications', with respect to a product 
        with labeling described in paragraph (1)--
                    ``(A) means oral, written, or electronic contact 
                between a manufacturer or distributor of such product 
                and an end user regarding the functioning of such 
                product; and
                    ``(B) includes any such contact consisting of 
                technical support, customer service, assistance with 
                the installation of such product, communication 
                relating to ensuring the performance of the product, 
                and other similar contacts.
            ``(3) Sunset.--This subsection shall cease to be effective 
        on the last day of the five-year period beginning on the date 
        of enactment of this section.''.
                                 <all>
```
##### 



Exhibit 32(b)
  
  (1)
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company, Peoples Gas
and North Shore Gas.
 /s/ Thomas A. Nardi
    
    
    
    December 14, 2005DateThomas A. NardiExecutive Vice President andChief Financial Officer ofPeoples Energy Corporation/s/ Thomas A. Nardi
    
    
    
    December 14, 2005DateThomas A. NardiExecutive Vice President andChief Financial Officer ofThe Peoples Gas Light and
Coke Company/s/ Thomas A. Nardi
    
    
    
    December 14, 2005DateThomas A. NardiExecutive Vice President andChief Financial Officer ofNorth Shore Gas Company
[Federal Register Volume 89, Number 186 (Wednesday, September 25, 2024)]
[Notices]
[Page 78305]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21788]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Delegation of Authority; Public Health Service Act

AGENCY: Centers for Disease Control and Prevention (CDC), the 
Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces the delegation of authority to the Head of 
Contracting Activity, Director Office of Acquisition Services, CDC. CDC 
has delegated the authority under section 305(e) of the Public Health 
Service Act (42 U.S.C. 242c), as amended, to (1) enter into 
transactions other than a contract, grant, or cooperative agreement for 
purposes of infectious disease research, bio-surveillance, infectious 
disease modeling, and public health preparedness and response for CDC. 
This includes the authority to award, modify, administer, and terminate 
other transactions; and (2) with respect to a project that is expected 
to cost more than $40,000,000, any delegated or redelegated authority 
under item (1) above to the Head of the Contracting Activity may only 
be exercised upon a written determination by the Assistant Secretary 
for Financial Resources, that the use of such authority is essential to 
promoting the success of the project. The authority of the Assistant 
Secretary for Financial Resources under section 305(e)(2) of the Act 
(42 U.S.C. 242c(e)(2)) as amended, may not be delegated. This authority 
may be redelegated unless redelegation is otherwise prohibited by law, 
regulation, other delegation, or policy.

DATES: This delegation was approved by the Director of CDC and became 
effective September 16, 2024.

FOR FURTHER INFORMATION CONTACT: Samantha Harrykissoon, Office of 
Policy, Performance, and Communication, Office of Financial Resources, 
Centers for Disease Control and Prevention, 4770 Buford Hwy., MS S102-
1, Atlanta, GA 30341. Telephone 770-488-2514; Email: <a href="/cdn-cgi/l/email-protection#e38c8591938c8f8a809aa3808780cd848c95"><span class="__cf_email__" data-cfemail="8ae5ecf8fae5e6e3e9f3cae9eee9a4ede5fc">[email protected]</span></a>.

Robin D. Bailey,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-21788 Filed 9-24-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
I 

114TH CONGRESS 

1ST SESSION H. R. 293 

To amend title XI of the Social Security Act to exempt from manufacturer 

transparency reporting certain transfers used for educational purposes, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 13, 2015 

Mr. BURGESS (for himself and Mr. DEFAZIO) introduced the following bill; 

which was referred to the Committee on Energy and Commerce, and in 

addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such 

provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To amend title XI of the Social Security Act to exempt 

from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


emcdonald on DSK67QTVN1PROD with BILLS
2 

•HR 293 IH

1 SECTION 1. EXEMPTING FROM MANUFACTURER TRANS2 PARENCY REPORTING CERTAIN TRANSFERS 

3 USED FOR EDUCATIONAL PURPOSES. 

4 (a) IN GENERAL.—Section 1128G(e)(10)(B) of the 

5 Social Security Act (42 U.S.C. 1320a–7h(e)(10)(B)) is 

6 amended— 

7 (1) in clause (iii), by inserting ‘‘, including 

8 peer-reviewed journals, journal reprints, journal sup9 plements, conference reports, and medical text10 books’’ after ‘‘patient use’’; and 

11 (2) by adding at the end the following new 

12 clause: 

13 ‘‘(xiii) A transfer of anything of value 

14 to a covered recipient who is a physician if 

15 the thing of value is intended solely for 

16 purposes of providing continuing medical 

17 education to the physician or other physi18 cians.’’. 

19 (b) EFFECTIVE DATE.—The amendments made by 

20 this section shall apply with respect to transfers of value 

21 made on or after the date of the enactment of this Act. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS
EXHIBIT 23
Consent of Independent Registered Public Accounting Firm
We consent to theincorporation by reference of our report dated March 14, 2005 with respect to theconsolidated financial statements and schedule of Penn Engineering & Manufacturing Corp. includedin this Annual Report (Form 10-K) for the year ended December 31, 2004, in the followingregistration statements:
   Penn Engineering & Manufacturing Corp. 1996 Equity Incentive Plan Form S-8 RegistrationStatement (Registration No. 333-20101);    Penn Engineering & Manufacturing Corp. 1996 Employee Stock Purchase Plan Form S-8Registration Statement (Registration No. 333-13073);    Penn Engineering & Manufacturing Corp. 1998 Stock Option Plan for Non-Employee DirectorsForm S-8 Registration Statement (Registration No. 333-92907);    Penn Engineering & Manufacturing Corp. 1999 Employee Stock Option Plan Form S-8Registration Statement (Registration No. 333-92903);    Penn Engineering & Manufacturing Corp. Dividend Reinvestment and Stock Purchase Plan FormS-3 Registration Statement (Registration No. 333-73450).    /s/ Ernst & Young LLP
Philadelphia, Pennsylvania
Exhibit 32.2








Chief Financial Officer’s Certification required under Section 906 of Sarbanes-Oxley Act of 2002





In connection with the quarterly report of TIB Financial Corp. (the “Company”) on Form 10-Q for the period ended June 30, 2010, as filed with the Securities and Exchange Commission (the “Report”), I, Stephen J. Gilhooly, Executive Vice President and Chief Financial Officer of the Company, certify pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that this Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that, to my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.








Date:           August 12, 2010
/s/ Stephen J. GilhoolyStephen J. Gilhooly

Executive Vice President, Chief Financial Officer and Treasurer (Principal Accounting Officer)











A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to TIB Financial Corp. and will be retained by TIB Financial Corp. and furnished to the Securities and Exchange Commission or its staff upon request.
#### WARD v. STATE.

No. 19515.

Court of Criminal Appeals of Texas.

Feb. 23, 1938.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

GRAVES, Judge.

Conviction for burglary; punishment, five years in the penitentiary.

There has been filed with the clerk of this court a proper affidavit certifying that pending appeal this appellant escaped from the custody of the sheriff on February 2, 1938, and has not been recaptured or returned to custody. Under the terms of our statute, Vernon’s Ann.C.C.P. art. 824, this court is without jurisdiction to further consider said appeal.

The appeal is dismissed.
United States Court of Appeals 

for the Fifth Circuit 

No. 21-40128 

Conference Calendar 

United States of America, 

Plaintiff—Appellee, 

versus

Hernan Garcia-Hernandez, 

Defendant—Appellant. 

Appeal from the United States District Court 

for the Southern District of Texas 

USDC No. 7:20-CR-1687-1 

Before Jones, Clement, and Haynes, Circuit Judges.

Per Curiam:*

The Federal Public Defender appointed to represent Hernan GarciaHernandez has moved for leave to withdraw and has filed a brief in 

accordance with Anders v. California, 386 U.S. 738 (1967), and United States 

v. Flores, 632 F.3d 229 (5th Cir. 2011). Garcia-Hernandez has filed a 

*

 Pursuant to 5th Circuit Rule 47.5, the court has determined that this 

opinion should not be published and is not precedent except under the limited 

circumstances set forth in 5th Circuit Rule 47.5.4. 

United States Court of Appeals 

Fifth Circuit 

FILED 

June 16, 2021 

Lyle W. Cayce 

Clerk 

Case: 21-40128 Document: 00515902123 Page: 1 Date Filed: 06/16/2021
No. 21-40128 

2 

response. We have reviewed counsel’s brief and the relevant portions of the 

record reflected therein, as well as Garcia-Hernandez’s response. We concur 

with counsel’s assessment that the appeal presents no nonfrivolous issue for 

appellate review. Accordingly, counsel’s motion for leave to withdraw is 

GRANTED, counsel is excused from further responsibilities herein, and 

the appeal is DISMISSED. See 5th Cir. R. 42.2. Garcia-Hernandez’s 

pro se motion for appointment of new counsel is DENIED as untimely. See

United States v. Wagner, 158 F.3d 901, 902-03 (5th Cir. 1998). 

Case: 21-40128 Document: 00515902123 Page: 2 Date Filed: 06/16/2021
Exhibit 99.2

                      Statement of Chief Financial Officer
         Pursuant to Section 1350 of Title 18 of the United States Code

         Pursuant to Section 1350 of Title 18 of the United States Code, I, Mark
W. Simon, the Senior Vice President, Chief Financial Officer and Corporate
Secretary of Penn Engineering & Manufacturing Corp. (the "Company"), hereby
certify that, to the best of my knowledge:

         1. The Company's Form 10-K Annual Report for the year ended December
31, 2002 (the "Report") fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


Date:  March 27, 2003                         /S/ MARK W. SIMON
                                              ----------------------------------
                                              Mark W. Simon, Senior Vice
                                              President, Chief Financial Officer
                                              and Corporate Secretary